Literature DB >> 34765688

A Cross-Sectional Comprehensive Assessment of the Profile and Burden of Non-motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort.

Oluwadamilola O Ojo1,2, Kolawole W Wahab3, Abiodun H Bello4, Sani A Abubakar5, Bertha C Ekeh6, Folajimi M Otubogun7, Emmanuel U Iwuozo8, Temitope H Farombi9, Olaleye Adeniji10, Francis I Ojini1,2, Frank A Imarhiagbe11, Yakub Nyandaiti12, Morenikeji A Komolafe13, Michael B Fawale13, Gerald A Onwuegbuzie14, Yusuf Zubair15, Uduak E Williams16, Funlola T Taiwo17, Shyngle I Oyakhire15, Olajumoke O Oshinaike18, Nosakhare Osemwegie19, Godwin O Osaigbovo20, Francis E Odiase11, Olanike A Odeniyi21, Yahaya O Obiabo22, Emmanuel E Obehighe23, Ernest O Nwazor24, Paul O Nwani25, Abiodun J Kehinde26, Cyril O Erameh27, Oluchi S Ekenze28, Franklin O Dike6, Salisu A Balarabe29, Ohwotemu Arigbodi30, Babawale Arabambi31, Ifeyinwa Ani-Osheku32, Mohammed W Ali33, John E Akpekpe34, Rufus O Akinyemi35, Uchechi Agulanna2, Christian E Agu36, Osigwe P Agabi2, Babatunde A Ademiluyi37, Akintunde A Adebowale13, Charles O Achoru20, Oladunni V Abiodun38, Mie Rizig39, Njideka U Okubadejo1,2.   

Abstract

BACKGROUND: Data on non-motor symptoms (NMS) in black Africans with Parkinson's disease (PD) are sparse.
OBJECTIVE: To describe the profile of NMS in the Nigeria PD Registry (NPDR) cohort and explore the relationship between NMS and PD motor phenotype.
METHODS: We conducted a cross-sectional study of the frequency and burden of NMS, based on the non-motor symptoms scale (NMSS) and the Chaudhuri method respectively in our cohort. Baseline demographics, disease characteristics (Hoehn and Yahr stage, MDS-UPDRS total score and Part III motor score), motor phenotype (based on Stebbin et al's algorithm), and levodopa equivalent daily dose (LEDD) were documented.
RESULTS: Data are presented for 825 PD whose mean age at study was 63.7 ± 10.1 years, female sex-221 [26.8%] while median PD duration was 36 months. PD phenotypes included tremor-dominant 466 (56.5%), postural instability and gait disorder (PIGD) 259 (31.4%), and indeterminate 100 (12.1%). 82.6% were on treatment (median LEDD of 500 mg/24 hours). 804 (97.5%) endorsed at least 1 NMS. The median NMSS score was 26.0 while subscores for urinary and sexual function domains were significantly higher in males (P < 0.05). PIGD-PD had more frequent NMS and higher frequency of severe/very severe NMSS burden (P = 0.000 for both). Nocturia and fatigue were the most prevalent NMS overall and across motor subtypes. PIGD phenotype and total UPDRS scores were the independent determinants of NMSS scores (P = 0.000).
CONCLUSION: The profile and burden of NMS, and association with motor subtype in our black African cohort is largely similar to descriptions from other populations.
© 2021 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Nigeria; Parkinson's disease; black African; burden; motor phenotype; non‐motor symptoms

Year:  2021        PMID: 34765688      PMCID: PMC8564828          DOI: 10.1002/mdc3.13346

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN: 2330-1619


  37 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Nonmotor Symptoms in Parkinson's Disease: Gender and Ethnic Differences.

Authors:  Anna Sauerbier; Abhishek Lenka; Azman Aris; Pramod Kumar Pal
Journal:  Int Rev Neurobiol       Date:  2017-07-14       Impact factor: 3.230

Review 3.  Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

Authors:  Kurt A Jellinger
Journal:  Int Rev Neurobiol       Date:  2017-06-27       Impact factor: 3.230

Review 4.  Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.

Authors:  Anna Sauerbier; Onanong Jitkritsadakul; Nataliya Titova; Lisa Klingelhoefer; Yoshio Tsuboi; Harry Carr; Hrishikesh Kumar; Rebecca Banerjee; Roberto Erro; Roongroj Bhidayasiri; Anette Schrag; Panagiotis Zis; Shen-Yang Lim; J Y Al-Hashel; Walaa A Kamel; Pablo Martinez-Martin; K Ray Chaudhuri
Journal:  Neuroepidemiology       Date:  2017-08-12       Impact factor: 3.282

Review 5.  Fatigue in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Mattia Siciliano; Luigi Trojano; Gabriella Santangelo; Rosa De Micco; Gioacchino Tedeschi; Alessandro Tessitore
Journal:  Mov Disord       Date:  2018-09-28       Impact factor: 10.338

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  Sydney Multicenter Study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years.

Authors:  Mariese A Hely; John G L Morris; Wayne G J Reid; Robert Trafficante
Journal:  Mov Disord       Date:  2005-02       Impact factor: 10.338

8.  How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.

Authors:  Glenn T Stebbins; Christopher G Goetz; David J Burn; Joseph Jankovic; Tien K Khoo; Barbara C Tilley
Journal:  Mov Disord       Date:  2013-02-13       Impact factor: 10.338

Review 9.  Non motor subtypes and Parkinson's disease.

Authors:  Anna Sauerbier; Peter Jenner; Antoniya Todorova; K Ray Chaudhuri
Journal:  Parkinsonism Relat Disord       Date:  2015-09-11       Impact factor: 4.891

10.  Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Cristian Falup Pecurariu; Per Odin; Jacobus J van Hilten; Angelo Antonini; Jose M Rojo-Abuin; Vanderci Borges; Claudia Trenkwalder; Dag Aarsland; David J Brooks; Kallol Ray Chaudhuri
Journal:  J Neurol       Date:  2012-01-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.